The following analysts provide research coverage of Human Genome Sciences, Inc. (NASDAQ: HGSI).
| Firm | Analyst | | Bank of America/Merrll Lynch | Rachel McMinn | | BernsteinResearch | Geoffrey C. Porges, MBBS | | Brean Murray Carrett | Brian Skorney | | Citigroup Investment Research | Yaron Werber, MD | | Collins Stewart | Salveen J. Richter, CFA | | Cowen and Company | Eric Schmidt, Ph.D. | | Credit Suisse | Ravi Mehrotra, Ph.D. | | Goldman, Sachs & Company | Terence Flynn, Ph.D. | | ISI Group, Inc. | Mark Schoenebaum | | JMP Securities | Liisa A. Bayko | | JPMorgan | Cory Kasimov | | Lazard Capital Markets | William Tanner | | Leerink Swann | Joseph P. Schwartz | | Morningstar Equity Research | Lauren Migliore | | Piper Jaffray | M. Ian Somaiya | | R.W. Baird | Christopher J. Raymond | | RBC Capital Markets | Michael Yee | | Summer Street Research | Carol Werther | | ThinkEquity | Marko Kozul |
|
 |
| Human Genome Sciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Human Genome Sciences's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Human Genome Sciences or its management. Human Genome Sciences does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. |
|
